Earnings Mentions for Johnson & Johnson

Historical counts of specific terms mentioned on earnings calls.

Transcripts Shown
Transcript Type
Overall Yes Rate49%
Next Earnings
Apr 14, 2026
Latest Transcript
Jan 23, 2026
China
Yes
0¢
No
100¢
24/24
Quarters w/ Yes
152Total Mentions
2025 Q4Last Mentioned
Carvykti
Yes
0¢
No
100¢
16/24
Quarters w/ Yes
133Total Mentions
2025 Q4Last Mentioned
Administration
Yes
0¢
No
100¢
9/24
Quarters w/ Yes
20Total Mentions
2025 Q4Last Mentioned
Darzalex Faspro
Yes
0¢
No
100¢
7/24
Quarters w/ Yes
10Total Mentions
2025 Q3Last Mentioned
AI / Artificial Intelligence
Yes
0¢
No
100¢
3/24
Quarters w/ Yes
3Total Mentions
2023 Q4Last Mentioned
You're only seeing data for 5 of 15 words. To see data for the words below, subscribe to our paid plan ($19.99/month).
Europe
Yes
0¢
No
100¢
--
Quarters w/ Yes
--Total Mentions
--Last Mentioned
Halda Therapeutics
Yes
0¢
No
100¢
--
Quarters w/ Yes
--Total Mentions
--Last Mentioned
Litigation
Yes
0¢
No
100¢
--
Quarters w/ Yes
--Total Mentions
--Last Mentioned
Nipocalimab / Lupus
Yes
0¢
No
100¢
--
Quarters w/ Yes
--Total Mentions
--Last Mentioned
Ottava
Yes
0¢
No
100¢
--
Quarters w/ Yes
--Total Mentions
--Last Mentioned
Procedure
Yes
0¢
No
100¢
--
Quarters w/ Yes
--Total Mentions
--Last Mentioned
Rybrevant
Yes
0¢
No
100¢
--
Quarters w/ Yes
--Total Mentions
--Last Mentioned
Tariff
Yes
0¢
No
100¢
--
Quarters w/ Yes
--Total Mentions
--Last Mentioned
Trufill
Yes
0¢
No
100¢
--
Quarters w/ Yes
--Total Mentions
--Last Mentioned
Vaccine
Yes
0¢
No
100¢
--
Quarters w/ Yes
--Total Mentions
--Last Mentioned